Profiel
James J.
Moon is the founder of EVOQ Therapeutics, Inc., founded in 2016, and holds the title of Chief Scientific Officer.
Former job includes Member-Scientific Advisory Board & Consultant at Elicio Therapeutics, Inc. (United States).
Education history includes a doctorate from William Marsh Rice University conferred in 2008 and an undergraduate degree from the University of California, Berkeley conferred in 2002.
Actieve functies van James J. Moon
| Bedrijven | Functie | Begin |
|---|---|---|
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Oprichter | 01-01-2016 |
Eerdere bekende functies van James J. Moon
| Bedrijven | Functie | Einde |
|---|---|---|
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Corporate Officer/Principal | - |
Opleiding van James J. Moon
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Elicio Therapeutics, Inc. (United States)
Elicio Therapeutics, Inc. (United States) BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel immunotherapies for treatment of cancer and other diseases | Health Technology |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Health Technology |
















